Can Applied Therapeutics Inc (NASDAQ: APLT) Still Be Considered A Loss When It’s Down -57.90% YTD?

During the last session, Applied Therapeutics Inc (NASDAQ:APLT)’s traded shares were 1.43 million, with the beta value of the company hitting 1.89. At the end of the trading day, the stock’s price was $0.36, reflecting an intraday loss of -4.40% or -$0.02. The 52-week high for the APLT share is $10.62, that puts it down -2850.0 from that peak though still a striking 19.44% gain since the share price plummeted to a 52-week low of $0.29. The company’s market capitalization is $51.04M, and the average trade volume was 2.29 million shares over the past three months.

Applied Therapeutics Inc (APLT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.25. APLT has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it.

Applied Therapeutics Inc (NASDAQ:APLT) trade information

Applied Therapeutics Inc (APLT) registered a -4.40% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.40% in intraday trading to $0.36, hitting a weekly high. The stock’s 5-day price performance is -4.60%, and it has moved by -8.18% in 30 days. Based on these gigs, the overall price performance for the year is -91.16%.

The consensus price target of analysts on Wall Street is $4.5, which implies an increase of 92.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4 and $5 respectively. As a result, APLT is trading at a discount of -1288.89% off the target high and -1011.11% off the low.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.57%. While earnings are projected to return 23.30% in 2025, the next five years will return 24.56% per annum.

APLT Dividends

Applied Therapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Applied Therapeutics Inc (NASDAQ:APLT)’s Major holders

The next largest institutional holding, with 9.54 million shares, is of VR ADVISER, LLC’s that is approximately 66.1112% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $44.57 million.

Also, the Mutual Funds coming in first place with the largest holdings of Applied Therapeutics Inc (APLT) shares are Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund. Data provided on Mar 31, 2025 indicates that Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF owns about 4.49 shares. This amounts to just over 3.17 percent of the company’s overall shares, with a $1.62 million market value. The same data shows that the other fund manager holds slightly less at 3.1, or about 2.19% of the stock, which is worth about $1.12 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.